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Abstract
Vogt-Koyanagi -Harada syndrome is an autoimmune, multisystem disease and important cause of uveitis. In this case 
report we address the significance of reliable diagnostics and including autoimmune diseases in differential diagnosis 
of uveitis and meningitis syndrome.
Sažetak
Vogt-Koyanagi-Harada sindrom je autoimuna, multisistemska bolest i važan uzrok uveitisa. Ovim prikazom bole-
snika naglašavamo važnost pouzdane dijagnostike te uključivanje autoimunih bolesti u diferencijalnu dijagnozu 
sindroma uveitisa i meningitisa.
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Introduction
 Uveitis is a form of eye inflammation which affects 
the middle layer of the eye wall (uvea). It is usually bi-
lateral and often accompanied by meningitis. Uveitis 
often presents with sudden symptoms and progresses 
quickly. A patient may experience eye redness, pain 
and blurred vision. The causes of uveitis are infection, 
injury or an autoimmune disease.
 Vogt-Koyanagi-Harada syndrome is a bilateral 
granulomatous uveitis based on autoimmune mecha-
nism. It is associated with serous retinal detachments, 
disk hyperaemia, oedema and vitritis, with or without 
extraocular manifestations on the skin, auditory or 
central nervous system. It mostly affects people be-
tween twenty and fifty years of age[1]. The incidence 
of this syndrome varies around the world. While it 
accounts for 1 to 4% of uveitis cases in the USA, it is 
responsible for 6 to 9% of uveitis cases in Japan.
 Due to such a wide spectrum of manifestations, 
typical cases of VKH syndrome are uncommon. In 
this case report we present a patient with Vogt-Koy-
anagi-Harada (VKH) syndrome and a false positive 
serology test to Borrelia burgdorferi. The aim of this 
case report is to address the significance of reliable di-
agnostics and inclusion of autoimmune diseases in dif-
ferential diagnosis of uveitis and meningitis syndrome.
Case presentation
 An adult 25-year-old female patient with unremark-
able medical history and no previous ocular surgery or 
trauma, experienced first symptoms two days prior to 
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admission. The patient provided us with the informa-
tion that she had experienced rapid onset frontal head-
ache and blurred vision on the left eye. Despite symp-
tomatic therapy for headache, frontal headache still 
persisted on the following day and blurred vision showed 
progression to both eyes. The patient was urgently ad-
mitted to University Hospital Dubrava on the same day. 
The neurological examination showed no evidence of 
central or peripheral deficits on admission and brain CT 
scan was without abnormalities. Subsequently, the pa-
tient was discharged home without therapy and referred 
to an ophthalmologist for further evaluation. On the 
third day of the illness, the patient was admitted to the 
University Hospital Centre Zagreb, Department of 
Neurology, where the ophthalmology examination in-
dicated exudative retinal detachment on both eyes 
(Figure 1). Ocular imaging modalities, including fluo-
rescein angiography, were suggestive of VKH (Figure 2).
Figure 1 Fundus photography at the time of admission to the hospital
Figure 2 Fundus fluorescein angiography at the time of admission to the hospital
 Further examination included an MRI that re-
vealed hyperintensive signal of the intrabulbar seg-
ment of the left optic nerve, pointing to optic neuri-
tis. At this stage, the patient was treated with pulse 
methylprednisolone therapy 1g/5 days. The patient’s 
condition improved and the treatment was contin-
ued with reduction in methylprednisolone dose. The 
laboratory examination of the cerebrospinal fluid 
(CSF) was negative for oligoclonal bands and NMO 
antibody test was also negative. CSF serology results 
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were as followed: CMV neg., Toxoplasma gondii neg., 
HSV1, HSV2 neg., B. burgdoferi positive. For the se-
rodiagnosis, the 2- test approach, using ELISA and 
Western blot, was performed. Positive IgM and IgG on 
the ELISA, along with a positive IgG on the Western 
blot, indicated an infection with B. burgdorferi. Con-
sequently, the patient was transferred to the University 
Hospital for Infectious Diseases „Dr. Fran Mihaljević” 
due to suspected neuroborreliosis. During hospitaliza-
tion, the symptoms aggravated to occipital headache, 
vision blurring and ear buzzing, which pointed to the 
need for increasing corticosteroid dosage. During 
follow-up, serology test for neuroborreliosis was re-
peated and the results were negative, which indicated 
that the previous one was false positive. The patient 
maintained without new symptoms during hospitali-
zation and at the end of the third week of the illness, 
the patient was dismissed. Throughout diagnosis and 
treatment, the patient was afebrile at all times. Final-
ly, the 7-month follow-up showed visual acuity being 
normal. The ophthalmology examination showed sig-
nificant reduction of the exudative retinal detachment 
(Figure 3) and the patient was prescribed therapy that 
included cyclosporine A 150+125 mg, methylpredni-
solone 7.5 mg, calcium 1000 mg and vitamin D 3-4 
drops.
Figure 3 Fundus photography at the 7-month follow-up
Discussion
 Differential diagnosis of uveitis should include in-
fectious (CMV, B.burgdorferi, TBC, syphilis, West Nile 
virus, leptospirosis, brucellosis) and non-infectious 
causes (Bechet’s disease, sarcoidosis, VKH syndrome, 
bilateral posterior scleritis, lupus choroidopathy, in-
traocular lymphoma, leukaemia)[3]. In this case, the 
typical symptoms, along with fundus ophthalmoscopy 
showing retinal detachment, were indicative of VKH 
syndrome. The proposed pathophysiology of VKH 
is based on a T-cell mediated autoimmune reaction 
against antigens of melanocytes, since these cells are 
found in all four affected tissues (eye, inner ear, brain, 
skin)[4]. The symptoms include blurred vision, pho-
tophobia, headache, vertigo, tinnitus, neck rigidity, 
vitiligo and alopecia. The diagnosis should be based 
on clinical findings, as well as ophthalmological im-
aging methods. The fundus fluorescein angiography 
was applied to confirm the diagnosis. The other meth-
ods, such as ICGA and OCT, have also been proven 
very useful in setting the diagnosis. Furthermore, in 
this particular case, the validity of serological testing 
to B.burgdorferi is compromised, leading to clinical 
confusion. After eliminating infectious etiology as a 
cause and repeated CSF serology negative on Borelia 
burgdorferi, based on characteristic abnormal ocular 
fundus findings and clinical manifestation, the final 
diagnosis was VKH syndrome.
 Our patient with Vogt-Koyanagi-Harada syndrome 
presented with blurred vision on the left eye and frontal 
headache. These symptoms are in correlation with pro-
dromal and beginning of uveitic stage of Vogt-Koyan-
agi-Harada disease (VGH). However, frontal headache 
and blurred vision are not specific for VGH. In the 
study by Shoughya and Tabbaraa, 9,2 % (7 out of 76) of 
patients with VGH had incorrect initial diagnosis. The 
initial diagnosis included optic neuritis, intracranial 
hypertension, brain tumour, Susac disease, migraine, 
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rhegmatogenous retinal detachment or anterior gran-
ulomatous uveitis of unknown etiology[5]. Even though 
the ophthalmologist suspected VGH disease after ex-
amining our patient, after MRI and CSF serology, the 
initial diagnosis was first optic neuritis and afterwards 
neuroborreliosis. The repeated CSF serology was neg-
ative for Borrelia burgdorferi, thus implying false posi-
tive result of previous serology. False positivity of Bor-
relia tests is a problem worldwide[6], with some reports 
of >20% false positivity from serum samples[7]. False 
positivity of Borrelia serology could result in unneces-
sary antibiotics administration and delayed initiation 
of therapy for conditions resembling neuroborreliosis 
symptoms. That, along with multiple conditions coin-
ciding symptoms of VGH, could result in later initia-
tion of VGH therapy (cyclosporine A /azathioprine 
and methylprednisolone), causing irreversible uveal 
damage resulting in poor visual acuity or vision loss.
 Fast, correct diagnosis and subsequent immunosup-
pressive treatment are of outmost importance, since 
without these, the disease could easily progress to its 
chronic phase and cause complications such as glauco-
ma, cataract, choroidal atrophy, vision loss. This paper 
highlights the importance of including autoimmune 
diseases in differential diagnosis and aggressive therapy. 
Rapid treatment with high dose corticosteroids, com-
bined with long-term corticosteroid and immunosup-
pressive therapy at appropriate dosage, minimizes 
these complications and improves visual prognosis.
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